Green Alpha Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Sell |
25,982
-1,249
| -5% | -$16.2K | 0.32% | 84 |
|
|
2025
Q1 | $288K | Buy |
+27,231
| New | +$288K | 0.31% | 86 |
|
|
2024
Q2 | – | Sell |
-8,414
| Closed | -$284K | – | 139 |
|
|
2024
Q1 | $284K | Buy |
8,414
+20
| +0.2% | +$675 | 0.21% | 124 |
|
|
2023
Q4 | $265K | Sell |
8,394
-13,144
| -61% | -$414K | 0.19% | 137 |
|
|
2023
Q3 | $550K | Sell |
21,538
-2,282
| -10% | -$58.3K | 0.42% | 89 |
|
|
2023
Q2 | $683K | Sell |
23,820
-615
| -3% | -$17.6K | 0.45% | 84 |
|
|
2023
Q1 | $586K | Buy |
24,435
+994
| +4% | +$23.8K | 0.41% | 94 |
|
|
2022
Q4 | $398K | Buy |
23,441
+79
| +0.3% | +$1.34K | 0.33% | 108 |
|
|
2022
Q3 | $346K | Sell |
23,362
-52,888
| -69% | -$783K | 0.29% | 120 |
|
|
2022
Q2 | $1.2M | Buy |
76,250
+53,237
| +231% | +$838K | 0.28% | 71 |
|
|
2022
Q1 | $620K | Buy |
23,013
+2,064
| +10% | +$55.6K | 0.42% | 98 |
|
|
2021
Q4 | $775K | Buy |
20,949
+726
| +4% | +$26.9K | 0.52% | 87 |
|
|
2021
Q3 | $966K | Buy |
20,223
+2,101
| +12% | +$100K | 0.67% | 73 |
|
|
2021
Q2 | $613K | Buy |
+18,122
| New | +$613K | 0.42% | 108 |
|